Peter Rowe

6.3k citations
81 papers · 3.9k indexed · h-index 36

Peter Rowe

80 papers receiving 3.8k citations

Peers

Peter Rowe
Comparison fields: 5 of 133
  • Nephrology 1.9k
  • Rheumatology 1.0k
  • Orthopedics and Sports Medicine 310
  • Genetics 985
  • Oncology 960
Replace Joseph Caverzasio with:
Joseph Caverzasio Switzerland
Su‐Li Cheng United States
Victoria Shalhoub United States
Kenneth B. Jonsson Sweden
Kazuma Tomizuka Japan
Yongbo Lu United States
Makoto Kakitani Japan
Marta Scatena United States
Janet E. Henderson Canada
Leonard Rifas United States
Peter Rowe relative to Joseph Caverzasio Switzerland Joseph Caverzasio's profile →
Citations per field
00.5×
Joseph Caverzasio · 1×
Citations per year

Countries citing papers authored by Peter Rowe

Since Specialization
Citations

This map shows the geographic impact of Peter Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rowe more than expected).

Fields of papers citing papers by Peter Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rowe. The network helps show where Peter Rowe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Rowe Line = papers co-authored together Peter Rowe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 201410
3 201452
4 201352
5 201252
6 2012115
7 201031
8 20109
9 2007135
10 200489
11 200247
12 200021
13 199825
14 1997129
15
The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism.
199723
16 1997160
17 199418
18 199411
19 199417
20 199214

About Peter Rowe

Peter Rowe is a scholar working on Nephrology, Rheumatology and Oncology, having authored 81 papers that have together received 3.9k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (41 papers), Bone health and treatments (25 papers), Bone and Dental Protein Studies (18 papers), Alkaline Phosphatase Research Studies (7 papers), Vitamin D Research Studies (6 papers), Genetic Syndromes and Imprinting (5 papers), Connective tissue disorders research (5 papers) and Biomedical Research and Pathophysiology (5 papers). The work is most often cited by research in Nephrology (1.9k citations), Rheumatology (1.0k citations) and Orthopedics and Sports Medicine (310 citations). Peter Rowe has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Anne-Marie Hedge, Michael J. Econs, Anthony W. Segal, C Oudet, Valentin David, Aline Martin, Carmel G. Teahan, Nick Totty, Peter J. Parker and L. Darryl Quarles. Their work appears in journals such as Bone, Genomics, Human Genetics, Journal of Clinical Investigation and American Journal of Physiology-Renal Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026